{"organizations": [], "uuid": "4e2d01bbb8d71b799f64c5dff27c1977da0c08f4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180507.html", "section_title": "Archive News &amp; Video for Monday, 07 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-suven-life-sciences-says-us-fda-is/brief-suven-life-sciences-says-u-s-fda-issued-eir-for-cos-facility-at-pashamylaram-idUSFWN1SE0E7", "country": "US", "domain_rank": 408, "title": "Suven Life Sciences Says U.S. FDA Issued EIR For Co's Facility At Pashamylaram", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.976, "site_type": "news", "published": "2018-05-07T16:19:00.000+03:00", "replies_count": 0, "uuid": "4e2d01bbb8d71b799f64c5dff27c1977da0c08f4"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-suven-life-sciences-says-us-fda-is/brief-suven-life-sciences-says-u-s-fda-issued-eir-for-cos-facility-at-pashamylaram-idUSFWN1SE0E7", "ord_in_thread": 0, "title": "Suven Life Sciences Says U.S. FDA Issued EIR For Co's Facility At Pashamylaram", "locations": [], "entities": {"persons": [{"name": "suven", "sentiment": "negative"}], "locations": [{"name": "pashamylaram", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "suven life sciences says u.s. fda issued eir for co", "sentiment": "negative"}, {"name": "suven life sciences ltd", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 7 (Reuters) - Suven Life Sciences Ltd:\n* SAYS SUVEN’S PASHAMYLARAM’S UNIT SUCCESSFULLY COMPLETES US FDA INSPECTION\n* FDA DETERMINED THAT THE INSPECTION CLASSIFICATION OF THIS FACILITY IS “NO ACTION INDICATED\n* BASED ON INSPECTION, FACILITY CONSIDERED TO BE IN ACCEPTABLE STATE OF COMPLIANCE W.R.T. CURRENT GOOD MANUFACTURING PROCESSES\n* FDA ISSUED ESTABLISHMENT INSPECTION REPORT FOR SUVEN FACILITY AT PASHAMYLARAM Source text - bit.ly/2KFOLJP\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "http://bit.ly/2KFOLJP", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-07T16:19:00.000+03:00", "crawled": "2018-05-08T16:22:34.003+03:00", "highlightTitle": ""}